
|Articles|September 1, 2002
FDT perimetry a better test of ganglion cell loss
Author(s)Laszlo Dosa
Fort Lauderdale, FL-Frequency doubling technology (FDT) perimetry appears to be a more sensitive visual field test for ganglion cell loss than traditional testing methods, according to Christopher A. Girkin, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Avisi Technologies releases positive 12-month data from VITA Trial
3
Sydnexis reports positive phase 3 results for SYD-101 in pediatric myopia
4
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
5


















































.png)


